Laboratory Corporation of America Holdings (NYSE:LH)
| 244.60 BATS BZX Real-Time Price As of May 13 |  -0.02 / -0.01%Today’s Change | 232.01 Today|||52-Week Range 317.17 | -22.15% Year-to-Date |
| SECTOR Health Services | INDUSTRY Services to the Health Industry | MARKET CAP $22.7B |
Company Description
Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.
Contact Information
Laboratory Corp. of America Holdings 358 South Main Street Burlington North Carolina 27215-5837 |
Employees
Shareholders
| Mutual fund holders | 48.38% |
| Other institutional | 43.04% |
| Individual stakeholders | 1.51% |
Top Executives
| Adam H. Schechter | Chairman, President & Chief Executive Officer |
| Glenn Andrew Eisenberg | Chief Financial Officer & Executive Vice President |
| Lance V. Berberian | Chief Information & Technology Officer & EVP |
| Brian J. Caveney | Chief Medical Officer, EVP & President-Diagnostics |
| Stephen M. Anderson | Chief Scientific Officer-Covance & Senior VP |
